Concepedia
Statistics
Publications
13
Citations
566
H-Index
Active since
1985
Affiliations
Novartis (Switzerland)(Current)
Ligand Pharmaceuticals (United States)
United States Pharmacopeial Convention
Earl F. Kimble is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and medicinal chemistry.
Publications per year
1985–2010
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2
Ronald E. Esser, Carol Berry, Zhengming Du et al. · British Journal of Pharmacology · 2005 · 123 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +13
Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase‐2
Jonathan N. King, Janet Dawson, Ronald E. Esser et al. · Journal of Veterinary Pharmacology and Therapeutics · 2009 · 78 citations · Full text
Medicine, Pharmacology, Cellular Pharmacology +12
Selective functional inhibition of JAK‐3 is sufficient for efficacy in collagen‐induced arthritis in mice
Tsung H. Lin, Martin Hegen, Elizabeth Quadros et al. · Arthritis & Rheumatism · 2010 · 74 citations
Medicine, Immunology, Pharmacology +16
Novel C5a Receptor Antagonists Regulate Neutrophil Functions In Vitro and In Vivo
Theodore C. Pellas, William C. Boyar, Jan van Oostrum et al. · The Journal of Immunology · 1998 · 59 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +10
The effects of diclofenac sodium on arachidonic acid metabolism
Edmond C. Ku, Warren Lee, Himanshu V. Kothari et al. · Seminars in Arthritis and Rheumatism · 1985 · 55 citations
Life Sciences, Biochemistry, Pharmacology +13
1–5 of 13